Emma Walmsley, GSK CEO (Credit: Fang Zhe/Xinhua/Alamy Live News)
August 22, 2022 12:31 PM EDTUpdated August 23, 06:18 AM
Pharma
Law

GSK to SCO­TUS: Don't take up 'skin­ny' gener­ic drug la­bel case

Zachary Brennan

Senior Editor

GSK made clear to the US Supreme Court on Fri­day that it should not re­vive its case against Te­va Phar­ma­ceu­ti­cals re­gard­ing so-called “skin­ny” gener­ic drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times